Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

Research and Innovation Action · Running

VIRTUAL BRAIN TWIN Virtual Brain Twin for personalised treatment of Psychiatric Disorders

Coordinator
Ebrains, Belgium
Runs
1 January 2024 to 31 December 2027
Status
Running
EU funding
€10.0m
Total cost
€10.0m
Partners
19 organisations in 9 countries
Type
Research and Innovation Action
Grant agreement
101137289

What the project is doing

In the project's own words, from its summary on CORDIS.

In the EU, about 165 million people are affected each year by mental disorders, and estimates indicate that mental disorders will become the number 1 economic cost factor in medicine in 2030. Schizophrenia alone affects approximately 1% of the world's population. The clinical effectiveness of the antipsychotics on the market remains limited with 30 to 50% of schizophrenic patients showing an insufficient response to treatment.

Several factors, from genetic to psychological and social, may lie behind poor treatment outcomes or side effects and varies from patient to patient. Therefore, the central aim of the VIRTUAL BRAIN TWIN project is to create an ecosystem for generating virtual brain twins for psychiatric patients, by leveraging the consortium’s detailed knowledge and expertise in neuronal microcircuit simulation, mathematical analysis, innovative AI tools, and psychiatric care and clinical studies.

This ecosystem will guide clinicians to optimise medication type and dosage, and to evaluate alternative treatments, such as brain stimulation and lifestyle changes. Multiscale cause-effect simulations and virtual brain simulations based on fMRI or sMRI data from the individual patient, will bridge the gap between molecules and the patient's brain. At the centre of this ecosystem will be the Virtual Brain Twin platform, which will make use of big data, multiscale modelling, and high-performance computing (HPC) that will be secured by appropriate data safety and protection.

The platform will be embedded in the European digital neuroscience research infrastructure EBRAINS and will be initially accessible to neuroscientists, clinical researchers, and mathematical modellers, and in the future, to clinicians, and patients as well. This ground-breaking project will pave the way for personalised treatment of psychiatric disorders, with the potential to significantly improve the quality of life of patients suffering from these conditions.

Topics

Who is involved

OrganisationCityCountryRole
EbrainsBruxelles / BrusselBelgiumCoordinator
Europese Federatie Van Familieverenigingen Van Psychiatrisch Zieke Personen IvzwLeuvenBelgiumParticipant
Global Alliance of Mental Illness Advocacy Networks Europe AisblBruxelles / BrusselBelgiumParticipant
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
Forschungszentrum Julich GmbHJulichGermanyParticipant
Klinikum Der Ludwig-Maximilians-Universitat MunchenMunchenGermanyThird party
Ludwig-Maximilians-Universitaet MuenchenPlaneggGermanyParticipant
Rheinische Friedrich-Wilhelms-Universitat BonnBonnGermanyParticipant
Athina-Erevnitiko Kentro Kainotomias Stis Technologies Tis Pliroforias, Ton Epikoinonion Kai Tis GnosisMaroussiGreeceParticipant
Universidad Politecnica De MadridMadridSpainParticipant
Universidad Rey Juan CarlosMostolesSpainParticipant
Association Europeenne De PsychiatrieStrasbourgFranceParticipant
Centre Hospitalier Regional De Marseille Assistance Publique-Hopitaux MarseilleMarseille Cedex 20FranceParticipant
Centre National De La Recherche Scientifique CNRSParisFranceParticipant
Universite D'aix MarseilleMarseilleFranceParticipant
Universita Degli Studi Di PaviaPaviaItalyParticipant
Universiteit Van AmsterdamAmsterdamNetherlandsParticipant
Codemart SRLCluj-NapocaRomaniaParticipant
Kungliga Tekniska HoegskolanStockholmSwedenParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI